Xiamen Amoytop Biotech Co., Ltd.
public_traded
Xiamen Amoytop Biotech Co., Ltd. is publicly traded on SHH under ticker 688278.SS.
Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.